Acucela Announces Official Name of Acucela Japan as Kubota Pharmaceutical Holdings Co., Ltd.

SEATTLE--(BUSINESS WIRE)--Acucela Inc. (Tokyo: 4589) (the “Company”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic disorders, announced today that, with requisite shareholder approval and effective at the conclusion of the proposed triangular merger (the “Triangular Merger”), the official name of Acucela Japan Kabushiki Kaisha (the “Japan Holding Company”) will become Ku